The annual event organized by the Argentine Chamber of Biotechnology featured a selection of scientific startups and brought together thousands of participants. The meeting promotes biotechnology in the country and the region.
The annual event organized by the Argentine Chamber of Biotechnology had its eighth edition and brought together thousands of participants virtually who listened to the Nobel Prize in Economics Michael Kremer and representatives of the innovative startups with global impact that are emerging in the country.
BioArgentina 2021, the annual and federal meeting that promotes biotechnology in the country and the region, was held this Thursday virtually and had the participation of miles of attendees who followed the live broadcast through different platforms.
The traditional event organized by the Argentine Chamber of Biotechnology (CAB) on its tenth anniversary was attended by the 2019 Nobel Prize in Economics, Michael Kremer and a selection of Argentine startups with global impact.
Paolo Rocca said that the State cannot continue to sustain informal employment and poverty
The opening of the 8th edition of BioArgentina was in charge of Federico Trucco, current president of the CAB, who thanked the presence of the Minister of Science, Technology and Innovation of the Nation, Daniel Filmus. “In difficult situations in the country, biotechnology has offered effective answers and solutions, that is why we have to continue promoting it and it should have a leading space in the discussion of the Argentina 2030 plan, with greater articulation between the public and private sectors and between basic and applied science, ”Filmus said.
After the beginning of the meeting, the director of Mabxience, Esteban Corley, presented the lecture by Michael Kremer, winner of the Nobel Prize in Economics in 2019, professor and director of the Innovation for Development Laboratory at the University of Chicago. During his talk, the special guest emphasized a broad definition of innovation that encompasses not only technologies, but also policies and new tools.
In this context, he highlighted related initiatives in which he has been working to combat inequality and poverty, such as dispensers for water treatment in Africa or digital agriculture systems. “Innovation leads to economic growth, can promote global health and fight poverty, but speed and access to this depend on social institutions”, He assured.
In the second block of BioArgentina 2021, 9 Argentine biotech startups were presented that are standing out in the entrepreneurial ecosystem. Coordinated by Matías Peiré, CEO and founder of GridX, they shared their experiences and explained why they have the potential to position the country as a leader in the global market.
The first to be presented was Food 4 you, by Antonieta Rodríguez de Olmos, which consists of a precision fermentation platform to improve plant-based foods, aimed at promoting the alternative protein industry. Then it was the turn of ArgenTAG, a startup that works in the world of genomic sequencing with potential applications in medicine and precision agriculture, which was presented by Leandro Ciappin. Infira, the company that is using molecules from perennial crops to apply them to annual crop production systems, was also part of the game and was presented by Renta Reinheimer.
The IMF considered that for the agreement to advance it must have “broad support” in Congress
Startups that are in more advanced instances were also found, such as Microgénesis, the company developed by Gabriela Gutiérrez and her team that created a low-cost self-administered kit that detects possible infertility problems caused by the imbalance of the female microbiome. From San Francisco, Elisa Bertini from CKapur, a startup that works to isolate Extremophilic microorganisms to promote agriculture in a sustainable way, joined. Bioheuris was another of the participating companies and its director of strategy, Carlos Pérez, referred to the use they make of synthetic biology and gene editing to develop herbicide-resistant crops.
In the last part of the day there were three of the companies with the longest journey. One of them was Chemtest, presented by Diego Comerci, who works on the use of nanotechnology for the area of diagnostics in human and veterinary health., noted for having developed a molecular test for the detection of the SARS-CoV2 virus. Then it was the turn of Inmunova, in charge of Linus Spatz, who specializes in the development of innovative treatments for rare diseases, such as Hemolytic Uremic Syndrome (HUS) and which served as the basis for the creation of the hyperimmune equine serum that was used. for the treatment of COVID-19 patients. Finally, Matías Veil presented Beeflow, the startup that works on “training” bees to enhance pollination and transform agriculture towards more sustainable ways.
The closing of BioArgentina 2021 was in charge of Graciela Ciccia, coordinator of CAB Startups, who highlighted the importance of being able to have a meeting of these characteristics 10 years after the foundation of the CAB. “The chamber brings together leaders from various sectors with ideas and actions that improve the world. We are united not only by the use of biotechnology of processes and products, but by the constant and continuous impulse of a constructive link with the scientific sector and public-private articulation ”, said the member of the CAB’s directive commission, highlighting that during Last year, in the midst of a pandemic, 57 startups joined the institution, which shows that excellent scientific ideas can be harmonized with entrepreneurial strength.
Capitanich wants to regulate the media: “People think what journalists propose”
We wish to give thanks to the writer of this article for this amazing web content
A Nobel Prize in Economics spoke at BioArgentina 2021